Is this you?
Claim your profile.

Brielle Benyon

Journalist

AS SEEN ON

CURE Media Group

Get in Touch

Geo Focus

United States (National)

Coverage Attributes:

Beta

Informative: 66 %

Data Driven: 33 %

Themes Covered:

Not enough data

Most Recent Topics:

Accessibility
Civil Rights
Diversity & Inclusion
Gender Issues
LGBTQ+ Interest
Men's Interest
Women's Interest

Pitching Insights

Brielle Benyon's coverage focuses heavily on healthcare and pharmaceutical topics, particularly in the field of oncology. The articles she covers often include data citations and expert commentary, indicating a strong emphasis on evidence-based reporting.

Given this focus, Brielle would likely be responsive to pitches from experts in the fields of oncology, cancer treatment, clinical trials, breast cancer research, and MPNs (Myeloproliferative Neoplasms). Sources with access to recent data or those who can provide insightful commentary based on evidence are also likely to resonate well with her.

As there is no specified geographic focus for Brielle's coverage area, relevant information or expertise from any location could be suitable for pitching.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Articles

CURE Media Group

FDA OKs Continued Enrollment in Ongoing Blood Cancer Clinical Trials After Gilead Addresses Safety Concerns

By: Brielle Benyon

Earlier in the year, clinical trials assessing magrolimab for myelodysplastic syndrome and acute myeloid leukemia were put on a partial clinical hold, but now the FDA said that they can start enrolling patients again.

CURE Media Group